Recombinant vaccinia viruses as vaccines
- 1 February 1986
- journal article
- Published by Springer Nature in Nature
- Vol. 319 (6054) , 549-550
- https://doi.org/10.1038/319549a0
Abstract
The prospect of live vaccines consisting of genetically modified vaccinia virus expressing foreign genes is exciting, but important issues concerning safety and efficacy need to be resolved.Keywords
This publication has 7 references indexed in Scilit:
- Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in MiceScience, 1985
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984
- Plasmodium knowlesi Sporozoite Antigen: Expression by Infectious Recombinant Vaccinia VirusScience, 1984
- Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.Proceedings of the National Academy of Sciences, 1983
- Infectious vaccinia virus recombinants that express hepatitis B virus surface antigenNature, 1983
- Vaccinia virus: a selectable eukaryotic cloning and expression vector.Proceedings of the National Academy of Sciences, 1982
- Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proceedings of the National Academy of Sciences, 1982